NSTM

$0.01+6.06%visit website

NovelStem International Corp.

Market Cap

$345,327.185

Live price × SEC shares (Aug 14, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

1.96

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

N/M

TTM to Jun 2026 · negative equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Total operating expenses	39	41	5	35	120
Operating income	(39)	(41)	(5)	(35)	(120)
Interest expense	0.0	0.0	36.0	0.0	36.0
Pretax income	(83)	(89)	(55)	(86)	(313)
Net income	(77)	(89)	(55)	(86)	(308)
EPS (basic) ($)			0.00	0.00	0.00
EPS (diluted) ($)			0.00	0.00	0.00
Weighted avg. shares (basic)	46,881		47,384	49,332
Weighted avg. shares (diluted)	46,881		47,384	49,332

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 14, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 30 more quarters, back to Jun 2010, with Tormere Pro.